{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Louisville&page=19&state=Kentucky", "query": { "state": "Kentucky", "city": "Louisville", "page": 19 }, "page_size": 10 }, "pagination": { "page": 19, "page_size": 10, "total_count": 1174, "total_pages": 118, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Louisville&page=20&state=Kentucky&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Louisville&page=18&state=Kentucky&page_size=10" }, "source": "local", "last_synced_at": "2026-10-21T00:25:36.564Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07089888", "title": "A Study of Dotinurad Versus Allopurinol in Tophaceous Gout", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tophaceous Gout" ], "interventions": [ { "name": "Allopurinol", "type": "DRUG" }, { "name": "Dotinurad", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Crystalys Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 250, "start_date": "2025-08-04", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-05T00:00:09.230Z", "location_count": 95, "location_summary": "Birmingham, Alabama • Foley, Alabama • Gilbert, Arizona + 85 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Foley", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07089888" }, { "nct_id": "NCT07089875", "title": "A Study of Dotinurad Versus Allopurinol in Participants With Gout", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Gout" ], "interventions": [ { "name": "Allopurinol", "type": "DRUG" }, { "name": "Dotinurad", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Crystalys Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 500, "start_date": "2025-08-01", "completion_date": "2027-11-29", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-14T19:01:32.197Z", "location_count": 95, "location_summary": "Birmingham, Alabama • Foley, Alabama • Gilbert, Arizona + 86 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Foley", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07089875" }, { "nct_id": "NCT06947993", "title": "Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "GHZ339", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 224, "start_date": "2025-05-16", "completion_date": "2028-12-22", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-15T05:51:31.802Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Fort Smith, Arkansas • Fountain Valley, California + 20 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06947993" }, { "nct_id": "NCT06819891", "title": "A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Moderately to Severely Active Crohns Disease" ], "interventions": [ { "name": "Afimkibart", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "16 Years to 80 Years" }, "enrollment_count": 425, "start_date": "2025-05-12", "completion_date": "2033-04-30", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-15T23:59:28.265Z", "location_count": 61, "location_summary": "Dothan, Alabama • Glendale, Arizona • Lancaster, California + 55 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Lancaster", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Pomona", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06819891" }, { "nct_id": "NCT06112418", "title": "A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus, Type 2", "Metabolic Syndrome", "PreDiabetes" ], "interventions": [ { "name": "The Cleerly CAD Staging System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Cleerly, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 7500, "start_date": "2024-03-06", "completion_date": "2029-03-05", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-14T11:11:32.046Z", "location_count": 125, "location_summary": "Chandler, Arizona • Scottsdale, Arizona • Sun City, Arizona + 100 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06112418" }, { "nct_id": "NCT05646862", "title": "A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Alpelisib", "type": "DRUG" }, { "name": "Bupropion", "type": "DRUG" }, { "name": "Fulvestrant", "type": "DRUG" }, { "name": "Inavolisib", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" }, { "name": "Omeprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 420, "start_date": "2023-06-07", "completion_date": "2029-03-30", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-21T00:25:36.564Z", "location_count": 39, "location_summary": "Greenbrae, California • Los Alamitos, California • Los Angeles, California + 32 more", "locations": [ { "city": "Greenbrae", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05646862" }, { "nct_id": "NCT05482893", "title": "Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Biliary Tract Cancer (BTC)", "Colorectal Cancer", "Gastric or Gastroesophageal Junction Adenocarcinoma", "Pancreatic Ductal Adenocarcinoma" ], "interventions": [ { "name": "Abraxane", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" }, { "name": "CAPOX", "type": "DRUG" }, { "name": "FOLFIRINOX", "type": "DRUG" }, { "name": "FOLFOX", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Gemcitabine Combined With Cisplatin", "type": "DRUG" }, { "name": "KEYTRUDA® (pembrolizumab)", "type": "DRUG" }, { "name": "NALIRIFOX", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Spevatamig (PT886)", "type": "DRUG" }, { "name": "TAS 102", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Phanes Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 350, "start_date": "2023-03-15", "completion_date": "2028-04", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-15T05:38:25.793Z", "location_count": 11, "location_summary": "Duarte, California • Los Angeles, California • Denver, Colorado + 8 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT05482893" }, { "nct_id": "NCT07518186", "title": "A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "JNJ-79635322", "type": "DRUG" }, { "name": "Teclistamab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 700, "start_date": "2026-05-31", "completion_date": "2032-12-08", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-20T16:20:09.595Z", "location_count": 41, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Springdale, Arkansas + 38 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Springdale", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07518186" }, { "nct_id": "NCT07298395", "title": "Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis (AD)" ], "interventions": [ { "name": "ENV-294", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Enveda Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 105, "start_date": "2025-12-22", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-16T20:20:05.336Z", "location_count": 32, "location_summary": "Birmingham, Alabama • Hot Springs, Arkansas • Beverly Hills, California + 27 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07298395" }, { "nct_id": "NCT07291427", "title": "Chronic Subdural Hematoma Embolization With Detachable Coils", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Subdural Hemorrhage (cSDH)" ], "interventions": [ { "name": "Balt coils: (Balt USA, LLC)", "type": "DEVICE" }, { "name": "MMA embolization", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2026-06-02", "completion_date": "2028-09-01", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-04T00:07:45.387Z", "location_count": 5, "location_summary": "Tucson, Arizona • San Deigo, California • Walnut Creek, California + 2 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "San Deigo", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT07291427" } ] }